|
|
||||||||
Automation and Analytical Techniques |
1
Swiss Federal Office of Public Health, Division of Food Science, Section of Food Chemistry and Analysis, 3003 Bern, Switzerland.
2
University of Bern, Inselspital, Department of
Pathology, 3010 Bern, Switzerland.
3
University Hospital, Inselspital, Department of Clinical
Chemistry, 3010 Bern, Switzerland.
a Author for correspondence. Fax (41) 31 322 95 74; e-mail max.haldimann{at}bag.admin.ch.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Switzerland was one of the pioneering countries in the prevention of IDDs by iodizing table salt. In 1922, iodized salt became commercially available for human consumption (4)(5) in that country. One of the earliest studies on the trace analytical chemistry, occurrence, and importance of iodine in various environmental and biological samples was published by this laboratory (Federal Office) in 1923 (6). At that time, the spectrophotometric method consisted of a simple optical device in which the color was visually perceived. Today, more sophisticated analytical methods have been established. Of the different methods available, the most commonly used is the sensitive spectrophotometric procedure based on the SandellKolthoff reaction, in which iodine has a catalytic effect on the reaction between cerium(IV) and arsenic(III) (7)(8)(9).
During the last 10 years, inductively coupled plasma mass spectrometry (ICP-MS) has become a popular method for the reliable determination of trace elements in samples of biological and environmental origin. Although iodine has a relatively high ionization energy (10 eV) and is, therefore, ionized in the plasma only to a limited extent (~25%), it can be readily determined by ICP-MS in a sensitive way. Several ICP-MS methods have been described for the determination of the total iodine content in biological materials (1015). However, only a few of these applications have been described for clinical chemistry (12)(15).
In many of the ionization methods used in mass spectrometry, the most accurate results can be obtained with isotope dilution analysis (IDA) (16)(17). For the determination of monoisotopic natural iodine, the long-lived radioisotope I is used for some IDA applications (17)(18)(19). I is produced either naturally by cosmic ray interaction with xenon in the atmosphere or as an artificial fission product of uranium or plutonium. Because I in environmental samples presently occurs in extremely low concentrations, its abundance in urine can be neglected (19)(20)(21). Even in urine samples from three technicians who disassembled the pressure vessel of a boiling water nuclear power reactor, I was not detected (detection limit, 0.01 µmol/L).
The I standard is radioactive; however, the analysis of ~20 000 urine samples per year does not represent a radiological hazard. Even if a person ingested the total amount of I necessary to carry out this number of measurements, it would cause only an effective dose equivalent of ~2 mSv/y, a dose that is comparable with the annual global average of human exposure to radiation from natural sources.
For the fourth time during this century, changes of dietary habits have made an increase of the iodine content in Swiss table salt mandatory (22)(23)(24). A longitudinal study to reassess the Swiss iodine status is planned. The aim of this work is to present a simple dilute-and-inject method for the determination of iodine in urine.
| Theory |
|---|
|
|
|---|
After adding the enriched solution, a mixture of I
and I, to the urine, the resulting I and
I intensity ratio R, which is measured
experimentally by ICP-MS, can be defined as:
![]() | (1) |
![]() | (2) |
![]() | (3) |
![]() | (4) |
The error of the measured isotope ratio contributes to the error of the
final iodine concentration and is theoretically expressed by a
nonlinear function of R. Optimal measurements are usually
achieved for R
1. However, for monoisotopic
elements such as iodine, the corresponding relation is linear
(16).
validation procedure
We applied four statistical linear regression models to estimate
the intercept (a) and slope (b) of the line
y = a bx: linear least-squares
regression, Bartlett's three-group method, orthogonal regression, and
maximum likelihood regression (25)(26)(27)(28)(29)(30)(31)(32). A gaussian
distribution was assumed for analytical errors, and alternatives were
not considered. Additional important assumptions in the first model are
that one method (x values) is without error, and the error
variances of y are constant over the concentration range.
The second model requires no knowledge of the error variances, and the
third model assumes a constant variance ratio. Theoretically, only the
maximum likelihood regression model gives correct estimates of
a and b even if the data are heteroscedastic, as
is typical in analytical chemistry. It applies statistical weight to
each point; therefore, determining the measurement variances for each
sample is necessary (28)(32).
| Materials and Methods |
|---|
|
|
|---|
Comparison method.
Analytical grade perchloric acid (70%),
nitric acid (65%), arsenic trioxide (As2O3),
ceric ammonium sulfate
[(NH4)4Ce(SO4)4]·2H2O,
and potassium iodate (KIO3) were obtained from Merck.
standards
I solution SRM 4949C was obtained from the
NIST (Gaithersburg, MD). The activity of the solution per unit mass was
certified at 3451 ± 22 Bq/g. A concentration of 4.09 ± 0.03
mmol/L (528 mg/L) I was calculated based on a half-life
of 1.57 x 10 years for I. The
concomitant quantity of natural I was not certified; it
was determined by ICP-MS using the standard addition method, which is
free from mass bias: 10 additions, in increasing increments of 8 nmol
I, to solutions containing 8 nmol I in 5
mL. An I concentration of 0.69 ± 0.03 mmol/L
(ns) was obtained. This corresponds to an
unbiased I and I ratio for the NIST
standard of 5.9 ± 0.2 (Rtrue).
Seronorm(TM) urine trace element control material (lot 403125) was obtained from Nycomed. No certified iodine concentration was given. The lyophilized urine was reconstituted with 5.0 mL water.
samples
The urine samples came from three healthy persons (1 male, 2
females; aged 6, 37, and 38 years) and were taken before and after
their exposure to a therapeutic saline bath containing an iodine
concentration of ~70 µmol/L, after which they inhaled an
iodine-rich vapor. A total of 60 collections were measured in the
Department of Clinical Chemistry of the University Hospital by the
comparison method. The samples were then stored in polystyrene tubes at
-20 °C. To have a broad range of concentrations, we selected 47
samples for triple determinations by ICP-MS according to their expected
iodine concentrations; however, we performed the analyses under blind
conditions. The samples were reconditioned at 35 °C for 1 h;
however, some of the precipitates did not dissolve completely. The
analysis of samples stored for several weeks at -20 °C did not show
any variation in iodine concentration with respect to those analyzed
earlier.
I solution and sample preparation and
measurement
NIST SRM 4949C control material (18.6 mg) was diluted to 150 mL
with 0.29 mol/L ammonia solution. This solution was freshly prepared
for each series of urine samples, consisting of 47 samples, that were
measured 3 times on different days.
The sample solutions consisted of 1.75 mL of the supplement solution and 0.75 mL of urine that were pipetted and dispensed using the automatic dilution device, Duo, from TAM. The settings for the volumes of sample and I solutions had been controlled previously using a PR/SR balance from Mettler. The resulting sample solution, containing 1.03 nmol (total of both isotopes) of the supplemented iodine, was shaken vigorously to mix the iodine isotopes completely. Fine precipitates, which sedimented to the bottom of the test tubes, were observed occasionally, but filtration was not necessary.
A reagent blank and an I solution were measured at
intervals of every 10th sample to detect any variation during the
measurement period. This control is of particular importance because
the mass bias correction factor f was determined based on
this ratio (Eq. 3
). Quantitative determinations of iodine
(I) were carried out by IDA according to the principles
outlined above (Eq. 4
).
instruments
A Perkin-Elmer Sciex Elan 5000 ICP-MS equipped with the
Perkin-Elmer AS90 autosampler and a parallel path high solids nebulizer
obtained from Technical Solutions were used. Because the efficiency of
a pneumatic nebulizer is <10%, the major portion of the iodine was
collected and pumped into a waste container. To avoid clogging the
nebulizer orifice, which may lead to an erratic loss of signal
intensity, the height of the autosampler capillary was adjusted to pump
the clear sample solution above the precipitates at the bottom of the
test tubes. Additional details of the instrument and operating
conditions are summarized in Table 1
.
|
principles of the comparison method
The comparison method was based on the SandellKolthoff reaction,
as described by Wawschinek et al. (33); the method has been
adapted to modern laboratory equipment by G. Bechtner (manuscript in
preparation) and modified in our laboratory by Wüthrich
(34). In contrast to the autoanalyzer methods, oxidation of
the iodine calibrators and urine samples for the comparison method was
performed manually in single glass tubes in a block heater. Urine
samples (0.4 mL) and KIO3 calibrators (0.4 mL) ranging from
0 to 3.0 µmol/L were added to 0.25 mL of a mixture (1:4 by volume) of
HNO3 (65%) and HClO4 (70%) and digested in
the block heater at a nominal 225 °C for 25 min. After the solution
cooled, 2 mL of water was added, and the solution was shaked; 100 µL
of this solution was then pipetted directly into 96-well microwell
plates. One hundred microliters of As2O3
solution (final As concentration, 40 mmol/L) and 50 µL of
(NH4)4Ce(SO4)3 solution
(final Ce concentration, 6.4 mmol/L) were added to each well. The
iodine calibrators were measured with each microplate. The absorption
was measured after a reaction time of 30 min by an automatic
microwell-plate reader (SLT-Labinstruments spectrophotometer) at 405
nm. Three replicates of each sample were analyzed consecutively.
The modified method was validated by use of primary reference standards (34) that were prepared, as were the calibrators, by directly weighing KIO3 to produce solutions whose concentrations are exactly known. In addition, the method was compared with the classical Technicon AutoAnalyzer method (35), which had been used for decades in our institute (23)(24)(36)(37). This comparison showed an excellent agreement between the two methods (34).
calculations
Calculations of the results of the ICP-MS ratio measurements
according to Eq. 4
were made with spreadsheet software (Excel, Ver.
5.0; Microsoft). The calibration curve for the spectrophotometric
comparison method was fitted using a cubic equation (spline), and the
results were computed using the Elias program (Elias
Medizinaltechnik).
In the method validation procedure, the parameters a and b estimated by the maximum likelihood regression were computed using the Systat 6.0 program (SPSS); all other regression models were computed using spreadsheet software.
| Results and Discussion |
|---|
|
|
|---|
The analysis of various sample series has never shown any cross-contamination. Urinary alkalinity promotes the precipitation of Mg3(PO4)2 and ammonium urate. Because the analytical results of measurements in both acidic and alkaline solutions were equal, it can be concluded that iodine did not coprecipitate with these fine residues.
Background.
Xenon occurs as an impurity in the argon plasma
gas. Therefore, its natural isotope, Xe, interferes with
the measurement of I, which can only be determined after
correction of the total ion intensity at m/z=129. This was
achieved either by measuring Xe and correcting the
Xe contribution proportional to its natural abundance or
by simply subtracting a reagent blank (0.2 mol/L ammonia solution
without I). Because there was no notable difference
between the two procedures, the latter was followed throughout this
work. However, the Xe signal was still monitored as an
additional check of possible instrumental instability. No noticeable
interference was found for iodine at the mass/charge ratio
m/z=127. The use of more expensive high purity argon
(99.9999%) lowered the Xe contribution to some extent;
however, a purity grade of 99.998% was sufficient for the
determination of urinary iodine. Under experimental conditions, the
maximum nonspecific signal contribution from Xe amounted
to 0.5% of the total signal at m/z = 129.
Matrix effects.
In addition to the background effects outlined
in the previous section, the sample matrix may also introduce changes
in the analyte signal intensity. Urine is a relatively complex matrix
and contains a wide variety of organic and inorganic substances at
variable concentrations. The signal responses of the I
isotope, which is present in equal concentrations in the urine sample
solutions, is shown in Fig. 1
. The two measurements, performed on different days, show
similar signal patterns with a day-to-day shift in intensities. In some
of the sample solutions, high concentrations of concomitant ions,
e.g., sodium chloride, severely suppressed the I
signal. IDA compensates for but does not eliminate such matrix effects.
The degree of suppression is the same for I and
I ions; thus the isotope ratio is not affected (Eq. 1
).
|
Detection limit.
The detection limit in IDA is related to the
quantity of added I (16). The isotope
enrichment of commercially available standards is rarely 100%; hence
the isotope that has to be determined is added in combination with the
enriched isotope. The addition of smaller supplemental quantities may
lower the detection limit to some extent. However, in this study, equal
amounts of I solution were added to each sample.
Therefore, the detection limit was estimated on the basis of the
isotope ratio measurements (Rexp) in solutions with added
I (16):
![]() | (5) |
|
Repeatability.
The repeatability, here defined as the ability
of a method to give the same answer when repeated several times in a
single day by a single analyst, was estimated and is summarized in
Table 3
. Pooled coefficients of variation (CVp) for the
ICP-MS method and comparison method of 2.5% (n = 20) and 4.2%
(n = 25), respectively, were calculated (38).
|
A scatter plot of ICP-MS vs spectrophotometric measurements is
shown in Fig. 2
; each of the crosses on the graph represents the mean values
and the SD of three replicates of a sample. Although not in a linear
manner, the SDs of both methods apparently increased with higher
concentrations (heteroscedastic), whereas the CVs did not.
|
For the comparison method, no proper between-run data were available because the replicates were measured consecutively. A CVp of 7.5% was obtained for the entire sample set (n = 47).
As a measure of the between-run precision of the ICP-MS method, a pooled CVp of 11.9% was obtained (n = 47). Previously, direct measurement of samples that had not been mineralized generally resulted in poorer precision (39). In addition, the instability of plasma, the mass spectrometer, and the ion optics impose limitations on the precision of the measured isotope ratios. However, the exact cause of variation was not identified or controlled and was, therefore, accepted as part of the variability of the method. The precision value, however, conformed to between-run CVs of 7.9% to 10.2% obtained by a method similar to the comparison method used in this study (40).
Accuracy.
Preliminary validations were made by measuring
various iodide solutions of known concentrations. The recoveries ranged
from 90% to 100%. So far, no urine control material that is certified
for iodine has been available commercially (41). The
Seronorm urine standard that adequately represents the matrix being
studied was measured by ICP-MS and the comparison method; values of
0.74 ± 0.01 µmol/L (n = 5) and 0.66 ± 0.03 µmol/L
(n = 10), respectively, were obtained. Because iodine was not
certified in this standard, the accuracy of the ICP-MS method was
validated by comparison of the mean iodine concentrations with the
results obtained from split samples analyzed by the comparison method.
Testing the accuracy of a method over the range of possible assay
values is a generally accepted practice. Intercepts (a) and
slopes (b) of the regression lines obtained by four
different statistical techniques are summarized in Table 4
.
|
The individual intervals for a and b at the 95%
confidence level include 0 and 1, respectively, and thus indicate an
absence of bias. The results in Table 4
show that there was no
systematic difference between the results of analytical methods within
the tested range of 0.2 to 2.8 µmol/L.
Thompson has shown that the consequences of the restrictions of the
conventional linear regression model are not serious, provided that at
least 10 samples cover the range of interest uniformly, and the method
with the smaller random errors is represented by the x-axis
(28). Thompson's assumptions were met in our data set, in
which the iodine concentrations covered the range from 0.2 to 2.8
µmol/L uniformly; moreover, no erratic points (outliers) were
observed. Therefore, the simple linear regression model gave valid test
results as well (Fig. 3
), which was confirmed by the other estimates.
|
Considering that the determinations were carried out in different laboratories that used methods based on completely different physical or chemical principles, the results of both methods are in excellent agreement. The close correlation between two such fundamentally different methods excludes any effects of possible interfering substances in the method, i.e., the comparison method, that theoretically bears a higher risk of interference artifacts. Both methods were comparable in performance capability, allowed precise adjustment and control of all the measurement parameters, and were, therefore, less susceptible to systematic errors. For example, in previous work, selenium was measured in human serum by graphite furnace atomic absorption spectrometry, and the uncontrollable deposition of carbonaceous residues in the graphite tube was a source of error (42). The agreement with the comparison method, ICP-MS (42), therefore, was not as good as in the comparison of interest in this work.
In conclusion, the results of this study show that the proposed ICP-MS
method provides a direct and accurate determination of iodine in human
urine with sufficient precision over a wide range of concentrations.
The steady throughput of
12 samples per hour may amount to >250
analyses per day, because the measurements can continue unattended
overnight. ICP-MS is a reasonable alternative to the classical
semiautomatic methods, which only allow 100200 tests per day
(9). In comparison with the established procedure based on
the SandellKolthoff reaction, a complete mineralization of the
samples is not necessary with the ICP-MS procedure; thus the operator
is not exposed to toxic agents. Moreover, ICP-MS might be used for the
monitoring of occupational exposure to I.
Although the instrumentation is expensive, the application of ICP-MS may become more popular in clinical chemistry in the near future because a potentially attractive feature of the technique is the ability to measure several trace elements simultaneously. However, for public health purposes, the method may be unrealistic for widespread use because of its high costs and degree of sophistication. A simple manual method for estimating the prevalence of IDD has been proposed recently (15).
A more detailed presentation and discussion on the absorption and excretion of iodine by humans as a result of exposure to iodine will be published elsewhere (manuscript in preparation).
| Acknowledgments |
|---|
| Footnotes |
|---|
2 5 Although the iodine in urine is mainly present as iodide, the term iodine is used throughout this study. ![]()
| References |
|---|
|
|
|---|
The following articles in journals at HighWire Press have cited this article:
![]() |
M. B Zimmermann, Y. Ito, S. Y Hess, K. Fujieda, and L. Molinari High thyroid volume in children with excess dietary iodine intakes Am. J. Clinical Nutrition, April 1, 2005; 81(4): 840 - 844. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Als, A. Helbling, K. Peter, M. Haldimann, B. Zimmerli, and H. Gerber Urinary Iodine Concentration follows a Circadian Rhythm: A Study with 3023 Spot Urine Samples in Adults and Children J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1367 - 1369. [Abstract] [Full Text] |
||||
![]() |
T. Ohashi, M. Yamaki, C. S. Pandav, M. G. Karmarkar, and M. Irie Simple Microplate Method for Determination of Urinary Iodine Clin. Chem., April 1, 2000; 46(4): 529 - 536. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |